TrialThe oncologist2023

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602).

Rudolph M Navari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.